Common Equity: The sum of all common equity items.
Aptevo Therapeutics Inc. (APVO) had Common Equity of $17.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.03M |
|
-- |
|
-- |
|
$7.61M |
|
$-7.61M |
|
$0.06M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.61M |
|
$-7.56M |
|
0.23M |
|
0.23M |
|
$-40.11 |
|
$-40.11 |
|
| Balance Sheet Financials | |
$22.65M |
|
$0.38M |
|
$4.35M |
|
$27.00M |
|
$5.61M |
|
-- |
|
$3.99M |
|
$9.60M |
|
|
Common Equity |
$17.39M |
$17.39M |
|
$17.39M |
|
0.77M |
|
| Cash Flow Statement Financials | |
$-20.36M |
|
-- |
|
$32.70M |
|
$8.71M |
|
$21.06M |
|
$12.35M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.41% |
|
-43.41% |
|
-27.96% |
|
-43.41% |
|
$22.65 |
|
$-90.42 |
|
$-90.42 |
|